Increasing studies suggest that T cells CD4 memory activated are associated with improved prognosis, such as in pancreatic adenocarcinomas, breast cancer, cervical cancer, and non-small cell lung cancer [24,32–34]. The gene discussed is CD4; the disease is breast cancer.